Skip to main content

Table 1 Demographics, clinical status, and pathology of iNPH cases

From: Diabetic phenotype in mouse and humans reduces the number of microglia around β-amyloid plaques

Group

Gender

Age (years)

Weight (kg)

Height (cm)

BMIa

HOMA-IRb

T2Dc

Hypertension

Aβ pathology

APOE genotype

BMI < 25

Female

67

70

170

24.2

0.6

no

no

positive

34

Male

79

65

168

23

2.7

no

no

positive

34

Male

75

56

159

22.2

0.7

no

yes

positive

44

Female

71

60

158

24

1.9

no

no

positive

33

avg.

73

63

164

23.4

1.5

    

BMI > 30

Female

71

87

160

34

4.9

no

no

positive

34

Male

81

102

171

34.9

7

no

no

positive

33

Male

69

80

160

31.3

3.4

no

yes

positive

33

avg.

73.5

89.8

166

32.6

5.1

    

BMI > 30 + T2D

Male

72

98

170

33.9

14.1

yes

yes

positive

33

Male

73

90

173

30.1

4.7

yes

yes

positive

34

Male

73

92

162

35.1

4.5

yes

yes

positive

33

Female

75

92

155

38.3

16.8

yes

yes

positive

34

Male

67

82

165

30.1

5.9

yes

yes

positive

34

avg.

72

90.8

165

33.5

9.2

    
  1. Age, Weight, Height, BMI and clinical status when biopsy was taken
  2. a Body Mass Index, weight (kg) / [height (m)]2
  3. b Homeostatic Model Assessment for Insulin Resistance
  4. c Type 2 Diabetes